MedPath

Effect of stretching exercise of diaphragm on lung functio

Not Applicable
Conditions
Covid 19 survivors.
Coronavirus as the cause of diseases classified elsewhere
B97.2
Registration Number
IRCT20211224053506N1
Lead Sponsor
Riphah international university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
53
Inclusion Criteria

COVID-19 survivors (i.e., diagnosed with COVID-19, have had respiratory illness and discharged from the hospital 6 weeks ago) No medical diagnosis of psychiatric illnessStated willingness to comply with all study procedures and availability for the duration of the studyAbility of participant to understand and the willingness to sign a written informed consent document.Hemoglobin of 9.0 gm/dl or higherCOVID-19 Survivor Group documented prior COVID-19 as evidenced by:At least 6 weeks ago since onset of COVID-19 symptoms and no fever for at least 1 week.
Aged 35 years or above. Gender (Male and Female)

Exclusion Criteria

Participants were excluded if they exhibited.Any person who experienced any back pain or who had experienced any type of illness in the past week were excluded from the study.(35)History of any of the following in the past 14 days: fever > 38.2 degrees Celsius; new or worsening respiratory symptoms (e.g. cough, dyspnea).Subjects were also excluded if they had received any manual therapy within the previous month.(35)Pregnancy Refusal to give consent

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spirometry. Timepoint: 1st week, 9th week, 18th week of treatment. Method of measurement: spirometer.
Secondary Outcome Measures
NameTimeMethod
6 minute walk test. Timepoint: 1st week, 9th week and 18th week of treatment. Method of measurement: walk test.
© Copyright 2025. All Rights Reserved by MedPath